Benztropine diminishes the impacts of specific chemicals in the body that might be unequal as an aftereffect of infection, (for example, Parkinson’s), medication treatment, or different causes.
Benztropine is utilized together with different drugs to treat the indications of Parkinson’s illness (muscle fits, firmness, tremors, poor muscle control).
Benztropine is additionally used to treat and keep these indications when they are created by medications, for example, chlorpromazine (Thorazine), fluphenazine (Prolixin), perphenazine (Trilafon), and others.
Submit your review
Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
fast or pounding heartbeats;
severe mouth dryness that causes trouble talking or swallowing;
loss of appetite, weight loss;
little or no urination;
blurred vision, tunnel vision, eye pain, or seeing halos around lights;
severe skin rash;
fever, severe weakness or dizziness; or
dehydration symptoms--feeling very thirsty or hot, being unable to urinate, heavy sweating, or hot and dry skin.
Side effects such as dry mouth, constipation, and confusion may be more likely in older adults.
Common side effects may include:
blurred vision; or
your eyes may be more sensitive to light.
Usual Adult Dose for Extrapyramidal Reaction: Acute dystonic reaction: Initial: 1 to 2 mg administered IM or IV one time usually relieves the acute condition. Maintenance: 1 to 2 mg orally administered once or twice a day as needed until the source of the dystonia (e.g., phenothiazine or other drug) has been removed. Once the offending agent has been discontinued, benztropine therapy should be continued for 24 to 72 hours, then ceased. Usual Adult Dose for Parkinson's Disease: Initial: 0.5 to 2 mg administered orally, IM, or IV, once a day. Idiopathic parkinsonism: start with a dose of 0.5 to 1 mg orally once daily at bedtime. postencephalitic parkinsonism: most patients require larger doses. It may be appropriate to initiate therapy at 1 to 2 mg orally once daily at bedtime. Maintenance: titration up from the initial dose should occur gradually by raising the dose in 0.5 mg increments every 5 to 6 days, up to 6 mg/day, until optimal relief is obtained. Usual Pediatric Dose for Extrapyramidal Reaction: 0 to 3 years: use of benztropine in this patient population should be restricted to life-threatening emergencies. > 3 years: 0.02 to 0.05 mg/kg administered orally, IM, or IV 1 to 2 times a day.